Metropolis Healthcare
METROPOLIS
Quick Bite
Price To Earnings Ratio 81.18 | Sector PE 65.63 |
PB Ratio 9.53 | Sector PB 8.94 |
EPS 24.95 | Dividend Yield 0.23 |
Today's Volume 94.129 K | 5 Day Avg. Volume 109.833 K |
PEG Ratio -7.68 | Market Cap. ₹ 10,420.00 Cr. |
Returns Comparison
| Time | METROPOLIS | VS | Industry |
|---|---|---|---|
| 1 Day | 1.88% | 1.74% | |
| 1 Week | 0.8% | 4.47% | |
| 1 Month | -2.93% | 9.12% | |
| 6 Months | -4.15% | 18.48% | |
| 1 Year | 22.2% | 42.12% |
Technical Trend
Pivot Levels
Moving Averages
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 2075.82 | Bearish |
| 20 | 2107.07 | Bearish |
| 30 | 2142.54 | Bearish |
| 50 | 2162.2 | Bearish |
| 100 | 2118.62 | Bearish |
| 200 | 1953.7 | Bullish |
Shareholding Updates
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 264.07 | 247.09 | 253.27 | ||||
| Investing Activities | -89.41 | 46.79 | -737.57 | ||||
| Financing Activities | -181.20 | -292.33 | 162.52 | ||||
| Net Cash Flow | -6.54 | 1.56 | -321.78 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Income Statement
Balance Sheet
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Metropolis Healthcare | 1.88 | 0.8 | -2.93 | -4.15 | 22.2 |
| Aarti Drugs | -2.11 | -4.16 | -7.78 | -3.52 | 1.84 |
| Abbott India | 2.27 | 0.68 | -3.61 | 3.38 | 20.65 |
| Advanced Enzyme Tech | -1.75 | -2.83 | -16.09 | -7.13 | 13.28 |
| Ajanta Pharmaceuticals | 0.73 | 5.25 | 1.62 | 13.32 | 47.04 |
About Metropolis Healthcare
Metropolis Healthcare Share Price
Metropolis Healthcare Limited is an Indian diagnostics company operating through the pathology services segment. The company offers a variety of clinical laboratory tests and profiles used for disease prediction, early detection, diagnostic screening, confirmation and monitoring. The company also provides analytical and support services to clinical research organisations for their clinical research projects. Its services include pathology testing services, corporate wellness, hospital laboratory and clinical research services. The company offers a variety of tests and profiles, which include advanced tests to diagnose cancer, neurological disorders, infectious diseases and various genetic abnormalities. It owns a chain of diagnostic centres in India, South Asia, Africa and the Middle East. The company has spread its footprint across 20 Indian states and over 210 cities.
Metropolis Healthcare FAQs
How to Buy Metropolis Healthcare Share?
What's Metropolis Healthcare share price today?
What is the Market Cap of Metropolis Healthcare?
What is the PE and PB ratio of Metropolis Healthcare?
What is the 52 Week High and Low of Metropolis Healthcare Share?